‘The representatives of Bharat Biotech are slated to meet WHO experts in a virtual meet at 4:45 pm. During the hour-long meeting, the vaccine manufacturer will present the clinical trial data of #Covaxin through all the three phases’ – Mirror Now
https://twitter.com/MirrorNow/status/1445342808647168000
16 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Marine Petroleum Trust (NASDAQ: MARPS) rose 25.4% to $6.29 in pre-market trading after gaining 8% on Monday.
WHO To Decide On EUL Of Ocugen-Partnered COVID-19 Vaccine Today
An expert panel of the World Health Organization (WHO) will decide on the emergency use listing (EUL) authorization of Covaxin today.
Covaxin is India's indigenously-developed COVID-19 vaccine, in collaboration with Ocugen Inc (NASDAQ: OCGN).
Ocugen 8-K Shows Co. Entered First Amendment To Deal With CanSino Biologics Related To Co.’s OCU410: Will Be Added To Co.’s Existing Collab With CanSino
On September 30, 2021, the Company entered into a First Amendment to the Co-Development and Commercialization Agreement (the “Amendment”) with CanSino Biologics, Inc. (“CanSino”) pursuant to which
India Today Reported on Saturday, Ocugen Partner Bharat Biotech Submitted Data to DCGI for Covaxin for Children Age 2 to 18
https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/bharat-biotech-submits-data-d
Ocugen Partner Bharat Biotech Tweets Regarding Potential Approval of Covid Vaccine by WHO: ‘We do not find it appropriate to speculate or comment on the regulatory approval process & its timeliness’
https://twitter.com/BharatBiotech/status/1442781421261578241
Ocugen-Partnered Covaxin’s WHO Clearance Delayed Further Over Queries: Sources
The World Health Organization (WHO) has further delayed the emergency use authorization (EUA) for Covaxin, a COVID-19 vaccine developed in India. Ocugen Inc (NASDAQ: OCGN) is the U.S. partner for the vaccine.
‘WHO’s Covaxin Clearance Delayed Further Over Technical Queries: Sources’ -NDTV Report
https://www.ndtv.com/india-news/covaxin-faces-more-delay-for-who-clearance-technical-queries-need-to-be-answered-by-bharat-biotech-sources-2555676
Ocugen To Participate In Fireside Chat At Cantor Global Healthcare Conference Sept. 28 at 8 a.m. EDT
Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced